You can buy or sell Charles River and other stocks, options, ETFs, and crypto commission-free!
Charles River Laboratories International, Inc., also called Charles River, is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. Read More The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
52 Week High
52 Week Low
Recent Performance: Charles River Laboratories International (NYSE: CRL)
Charles River Laboratories International is in the healthcare sector and medical diagnostics and research industry. The company CEO is James C. Foster. Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries. Previous Intraday Trading Performance: The CRL stock showed a previous change of 0.63% with an open at 145.63 ...
Yahoo FinanceMar 15
At US$141, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?
Charles River Laboratories International, Inc. (NYSE:CRL), which is in the life sciences business, and is based in United States, received a lot of attention from a substantial price increase on the NYSE over the last few months. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Charles River Laboratories Internation...
Simply Wall StMar 12
How Many Insiders Sold Charles River Laboratories International, Inc. (NYSE:CRL) Shares?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Charles River Laboratories International, Inc. (NYSE:CRL). What Is Insider Selling? It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, most ...
Expected May 9, Pre-Market